Abiopharma

🔍 Cormier Renae Terese (Executive)

Company: ProCap Financial, Inc. (BRR)

Report Date: 2026-03-23

Detailed Transactions and Holdings:

• Acquired 157,443 shares of Common Stock, par value $0.001 (Direct)
  Date: 2026-03-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 157,443.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 74,278 shares of Common Stock, par value $0.001 at $2.62 per share (Direct)
  Date: 2026-03-23 | Code: F | equity_swap_involved: 0 | shares_owned_after: 83,164.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents the settlement of restricted stock units ("RSUs") into shares of common stock upon vesting. Each RSU represents a contingent right to receive one share of common stock.
• F2: Represents shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs.The reporting person received the net number of shares after the issuer withheld shares to satisfy applicable tax withholding obligations.